For decades, our businesses have served the health and life sciences industry to create real impact. Today, we reignite a new spark, evolving from Inizio Advisory to Inizio Ignite, bringing together our businesses – Putnam, Research Partnership, STEM, and Vynamic – to operate as one.

Our vast expertise across our teams allows us to tap into a greater level of depth and breath – an opportunity to cross–collaborate with scale. This evolution allows us to better serve you, our clients.
Together, we collaborate with you to ignite impact, accelerate performance, and deliver lasting change for patients. By uniting strategy, insights, and innovation with a unique depth and breadth of expertise, we drive transformation and shape the future of health.
Our Putnam strategy consulting team bridges science and strategy to enable confident decision-making and build value for pharma. We partner with leading health and life science companies serving brand & commercial leaders, Medical Affairs, access & pricing, and R&D. Our expertise spans offerings including:
Our Vynamic management consulting team connects strategy to action, driving healthcare transformation. We partner with leading health and life science companies serving brand & commercial, Medical affairs, R&D, and Health Services, our expertise spans offerings including:
Our Research Partnership healthcare market research team provides research and insights to inform and power healthcare decisions. Serving a variety of clients across the lifecycle, our expertise includes:
Our STEM team uses benchmarking through AI-enabled and evidence-based approaches to drive alignment resulting in accelerated performance. Serving clients across brand & commercial, Medical Affairs, & Sales, our expertise includes:
Unmatched scientific and technical domain expertise enabled by technology and AI.
Real business outcomes powered by evidence, insights, and long-term partnership.
Unified client experience through connected expertise, shared purpose, and high-quality delivery.
As President of Putnam, Matt leads a team focused on strategic acuity and patient impact. He has partnered with global biopharma across therapeutic areas from pipeline shaping to launch, applying structured thinking and objective analysis to drive results.
With a broad experience in the pharmaceutical industry spanning over more than 25 years, Dermot joined STEM as CEO in November 2021. As CEO, Dermot is responsible for driving growth and innovation within STEM.
As President of Vynamic, Haben Debessay leads efforts to shape the future of healthcare through bold, strategic change. With more than two decades of experience in consulting and operational leadership, Haben helps clients and teams connect vision to execution—translating complex challenges into transformative outcomes that advance business performance.
We help you to formulate your strategy, defining where to compete and how to succeed. This involves strategic planning and necessary transformations informed by deep expertise, research, and insights. We bridge the gap between ambition and execution, guiding tactical decisions and measuring performance against proprietary benchmarking data to ensure lasting success.
Let’s discuss how we can help you.
To explore career opportunities with Inizio, visit our vacancies page or join our Talent Community.